Search Results - "Teresk, Martin"
-
1
Thermodynamic and Structural Effects of Conformational Constraints in Protein−Ligand Interactions. Entropic Paradoxy Associated with Ligand Preorganization
Published in Journal of the American Chemical Society (25-11-2009)“…Succinate- and cyclopropane-derived phosphotyrosine (pY) replacements were incorporated into a series of Grb2 SH2 binding ligands wherein the pY+1 residue was…”
Get full text
Journal Article -
2
Deficiencies in Traditional Oral Dosage Forms and the Emergence of Controlled-Release Powder Manufacturing
Published in KONA Powder and Particle Journal (2017)“…The importance of providing safe and effective delayed- and extended-release oral formulations that can replace products requiring multiple administrations has…”
Get full text
Journal Article -
3
Ligand Preorganization May Be Accompanied by Entropic Penalties in Protein-Ligand Interactions
Published in Angewandte Chemie International Edition (20-10-2006)“…Fact or fiction? It is generally assumed that preorganization of a flexible ligand in the 3D shape it adopts when bound to a macromolecular receptor will…”
Get full text
Journal Article -
4
Evaluation of solution oxygenation requirements for azonitrile-based oxidative forced degradation studies of pharmaceutical compounds
Published in Journal of pharmaceutical sciences (01-07-2006)“…AIBN and ACVA oxidative forced degradation models are examined for two drug molecules whose predominant oxidation chemistries arise from different reaction…”
Get more information
Journal Article -
5
A phase 2 basket trial of ulixertinib (BVD-523) in combination with hydroxychloroquine in patients with advanced gastrointestinal malignancies harboring MAPK pathway mutations (BVD-523-HCQ)
Published in Journal of clinical oncology (01-06-2023)“…TPS4174 Background: RAS-induced signaling through the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway plays an…”
Get full text
Journal Article -
6
Abstract B085: Preclinical pharmacokinetic/pharmacodynamic (PK/PD) relationship demonstrated for BVD-723, a potent and selective phosphoinositide 3-kinase gamma (PI3Kγ) inhibitor
Published in Molecular cancer therapeutics (01-01-2018)“…Abstract The phosphoinositide 3-kinase (PI3K) family of enzymes play a pivotal role in controlling vital cellular functions, including proliferation, motility,…”
Get full text
Journal Article -
7
Abstract 2693: Combining ulixertinib (ERK1/2 Inhibitor) with EGFR and BRAF inhibition yields significant efficacy in preclinical BRAF V600E mutant colorectal cancer models
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract The BRAFV600E mutation occurs in approximately 7% of colorectal cancer (CRC). BRAF plus EGFR inhibition (encorafenib with cetuximab) is an FDA…”
Get full text
Journal Article -
8
Abstract 2692: The combination of ulixertinib (ERK1/2 Inhibitor) and KRASG12C inhibition demonstrates significant efficacy in preclinical models
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Ulixertinib (BVD-523) is a first-in-class and best-in-class small molecule inhibitor of ERK1/2 currently being investigated in several oncology…”
Get full text
Journal Article -
9
Design, synthesis & thermodynamic evaluation of conformationally-constrained pseudopeptides and synthetic approaches to sieboldine A
Published 01-01-2008“…A series of conformationally constrained and flexible pseudopeptides were prepared and their thermodynamic parameters on binding to the Grb2 SH2 domain were…”
Get full text
Dissertation -
10
Ligand Preorganization May Be Accompanied by Entropic Penalties in Protein-Ligand Interactions
Published in Angewandte Chemie (20-10-2006)“…Fakt oder Fiktion? Es wird allgemein angenommen, dass die Präorganisation eines flexiblen Liganden zu der dreidimensionalen Form, die er bei der Bindung an…”
Get full text
Journal Article -
11
Ligand Preorganization May Be Accompanied by Entropic Penalties in Protein–Ligand Interactions
Published in Angewandte Chemie (20-10-2006)Get full text
Journal Article